At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings
By Jeff Overley · August 18, 2026, 10:54 PM EDT
The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat...
To view the full article, register now.